84 results on '"Hicks, R."'
Search Results
2. P2.01-01 Initial Result of the ImmunoPET Phase1 Study: Characterising PD-L1 During Chemoradiotherapy with 89Zr- Durvalumab (MEDI4736) PET/CT
3. PD-0971 Radiation dose response of bone marrow during chemoRT for NSCLC measured by serial FLT-PET
4. MO-0473 Lymphopenia during NSCLC ChemoRT is proportional to FLT-detected suppression of irradiated marrow
5. PD-0970 Biodistribution Data of ImmunoPET: A Phase 0/1 Study Characterising PD-L1 with 89Zr- Durvalumab
6. 13 A North American provider survey of cystic fibrosis–related diabetes screening practices
7. 577O PRINCE: Interim analysis of the phase Ib study of 177Lu-PSMA-617 in combination with pembrolizumab for metastatic castration resistant prostate cancer (mCRPC)
8. POS-476 OPTIMIZATION OF SDS-BASED KIDNEY DECELLULARIZATION RESULTS IN ECM SCAFFOLDS APPLICABLE FOR 3D RECELLULARIZATION
9. High Rate of Abscopal Regression of Follicular Lymphoma after Low Dose Involved-Site Radiation Therapy Detected by FDG-PET Scans
10. P.218Utility based health related quality of life in children and adolescents with spinal muscular atrophy
11. Enhancing PET signal at target tissue in vivo: dendritic hydroxypyridinone peptide conjugates for molecular imaging with gallium-68
12. A Prospective Study of F-18 Fluoro-methyl-choline (FCH) And Ga-68 HBED-CC- (PSMA) in Men being Considered for Salvage Radiation Treatment for Biochemical Failure Post Radical Prostatectomy
13. Unravelling mechanisms of toxicity induced by classical PPAR-gamma agonists through transcriptomic analysis of hiPSC-derived kidney organoids
14. Prospective, multinational comparison of magnetic resonance imaging (mp-MRI and WB–MRI) F-18 fluorocholine (FCH) and Ga-68 PSMA in high risk men being considered for salvage radiation treatment for biochemical failure post radical prostatectomy
15. P2.14-001 Mid-Treatment Perfusion PET/CT Is More Effective Than Ventilation PET/CT in Functionally-Adapted Radiotherapy for NSCLC
16. Prognostic impact of early complete metabolic response on FDG-PET, in BRAF V600 mutant metastatic melanoma patients treated with combination vemurafenib & cobimetinib
17. Can Positron Emission Tomography (PET) Complement Conventional Staging of Early-Stage Testicular Seminoma?
18. 561 Evaluation of detection rate of 68Ga-PSMA PET/CT for biochemical recurrence after radical prostatectomy
19. Age and Gender Differences in the Distribution of Proliferating Bone Marrow in Adults Measured by FLT-PET/CT Imaging With Potential Application for Radiation Therapy Planning
20. Impact of 18-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Stage on Outcomes Among Patients With Early-Stage Follicular Lymphoma
21. Next-to-leading order QCD analysis of polarized deep inelastic scattering data
22. Feasibility of IMRT Planning to Reduce Dose to Functional Lung Using Respiratory Gated (4D) Gallium-68 Perfusion PET/CT
23. OC-0364: Impact of imaging and pathological biomarkers on survival after chemoradiation of locally advanced cervical cancer
24. Autologous peripheral blood T lymphocytes transduced with an anti lewisy chimeric receptor gene can be infused safely and persist in patients with lewisy positive acute myeloid leukaemia
25. FDG-PET Scanning has a High Impact on the Management of Patients With Merkel Cell Carcinoma
26. 99 Proffered Paper: The Importance of Glycolysis for the Response and Resistance of BRAFV600E Human Melanoma Cells to Vemurafenib
27. OC-0125 LONG-TERM OUTCOMES OF A PROSPECTIVE STUDY OF POST-THERAPY PET AFTER CHEMORADIATION OF CERVICAL CANCER
28. Post-therapy Positron Emission Tomography may Obviate the Need for Conventional Follow-up in Patients Receiving Chemoradiation for Advanced Cervical Cancer
29. 9119 POSTER Combination of Pertuzumab and Erlotinib as 2nd-/3rd-Line (2/3L) Treatment for Patients (pts) With Metastatic Non-Small Cell Lung Cancer (NSCLC) – Safety and Anti-Tumour Activity by FDG-PET/CT Imaging Changes
30. Results of a Prospective Clinical Trial of FDG-PET/CT Scanning for Staging and Treatment Planning in Candidates for Radical Radiation Therapy with Unresectable Non-small Cell Lung Cancer
31. 41 poster: Biologically Guided Radiation Therapy: Quality Assurance and Resource Implications in Longitudinal PET/CT Studies
32. Using Molecular Imaging to Quantitatively Estimate the Distribution of Proliferating Bone Marrow in Adult Cancer Patients
33. The use of FDG-PET Scanning (PET) in the Management of Merkel Cell Carcinoma
34. Reproducibility of “Intelligent” Contouring of Gross Tumor Volume in Non-Small Cell Lung Cancer on PET/CT Images Using a Standardized Visual Method
35. Atmospheric plasma deposition of glass coatings on aluminum
36. An optical navigation sensor for micro aerial vehicles
37. 2457
38. 89 Clinical impact of F-18 fluorodeoxyglucose positron emission tomography (PET) on the management of primary tumours of the thymus
39. 72 Targeting the cell cycle in combination with radiotherapy or chemotherapy
40. 75 Can hypoxia imaging be used to identify patients for tirapazamine-based therapy?
41. Non-invasive energy spread monitoring for the JLAB experimental program via synchrotron light interferometers
42. Long-Term Follow-up of 153 Candidates for Definitive Radiation or Chemoradiation Therapy with Non-Small Cell Lung Cancer Who Were Staged by PET: Implications for Design of Future Randomized Trials
43. P-703 Fused PET/CT images for planning radical radiotherapy (RRT) fornon-small cell lung cancer (NSCLC)
44. NOVEL EVALUATION OF PSEUDOANAPHYLAXIS TO FOOD. - F5
45. In regard to Paulino and Johnstone: Use of PET and CT imaging data in radiation therapy planning. Int J Radit Oncol Biol Phys 2004;59:4–5
46. How should we introduce clinical positron emission tomography in the UK? Oncologists need to have a (clearer) view
47. Early FDG-PET imaging after radical radiotherapy for non-small cell lung cancer: Inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation
48. Thallium-201 scintigraphy–a predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy?
49. Patterns of failure in patients who had response-assessment by PET after radical radiotherapy for non-small cell lung cancer support the case for more intensive local therapy
50. Measurement of the transverse–longitudinal cross sections in the π reaction in the Δ region
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.